EHRA Issues Guide for New Afib Drugs

Register Today

Earn Free CME Credits by reading the latest medical news
in your specialty.

Sign Up

38762

By Chris Kaiser, Cardiology Editor, MedPage Today

Published: April 30, 2013

Reviewed by F. Perry Wilson, MD, MSCE; Instructor of Medicine, Perelman School of Medicine at the University of Pennsylvania

Action Points

  • Note that this guidance document from the European Heart Rhythm Association provides clinical support for the management of nonwarfarin anticoagulants in atrial fibrillation.
  • Be aware that the quality of evidence for most of the recommendations is quite low (primarily expert opinion).

Skin Cancer Tx No Help for Sick Older Patients?

Register Today

Earn Free CME Credits by reading the latest medical news
in your specialty.

Sign Up

38749

By Cole Petrochko, Staff Writer, MedPage Today

Published: April 29, 2013

Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco

Action Points

  • Surgical treatment of nonmelanoma skin cancer in elderly patients with other underlying health conditions may do more harm than good.
  • Note that 43% of patients with limited life expectancy and nonmelanoma skin cancer died within 5 years of the study baseline from complications unrelated to their skin cancer.

U.S.-born kids have more allergies, asthma

By Genevra Pittman

NEW YORK | Mon Apr 29, 2013 4:04pm EDT

NEW YORK (Reuters Health) – Kids and teens who are born abroad and immigrate to the United States are about half as likely to have asthma and allergies as those who are born in the U.S., according to a new study.

Researchers surveyed the parents of 80,000 children in one of six languages and found that association held even after they took into account where families lived and how often they moved, as well as their race and income.

Should old, sick patients get skin cancer surgery?

By Genevra Pittman

NEW YORK | Mon Apr 29, 2013 4:02pm EDT

NEW YORK (Reuters Health) – More than two-thirds of people with non-melanoma skin cancer underwent surgery to treat the condition, according to a new study – including patients who were at least 85 years old or had multiple other chronic diseases.

Researchers found 43 percent of those patients with limited life expectancies died within five years of their diagnosis – but none from skin cancer. Many of them reported poor wound healing after skin surgery or other treatment-related complications including pain, numbness and itching.

Parasite 'resistant to malaria drug'

28 April 2013 Last updated at 20:03 ET

By Rebecca Morelle Science reporter, BBC World Service

Plasmodium falciparumThe malaria-causing parasites in Cambodia were genetically different from other strains

New drug-resistant strains of the parasite that causes malaria have been identified by scientists.

Researchers found parasites in western Cambodia that are genetically different from other strains around the world.

These organisms are able to withstand treatment by artemisinin – a frontline drug in the fight against malaria.

Reports of drug resistance in the area first emerged in 2008. The problem has since spread to other parts of South East Asia.

Parasite ‘resistant to malaria drug’

28 April 2013 Last updated at 20:03 ET

By Rebecca Morelle Science reporter, BBC World Service

Plasmodium falciparumThe malaria-causing parasites in Cambodia were genetically different from other strains

New drug-resistant strains of the parasite that causes malaria have been identified by scientists.

Researchers found parasites in western Cambodia that are genetically different from other strains around the world.

These organisms are able to withstand treatment by artemisinin – a frontline drug in the fight against malaria.

Reports of drug resistance in the area first emerged in 2008. The problem has since spread to other parts of South East Asia.

MS patients missing out on drugs

28 April 2013 Last updated at 21:42 ET

A woman taking a drug treatment for multiple sclerosis

Only 40% of people eligible for drugs to combat multiple sclerosis in the UK are actually taking them, says a report from the MS Society.

A survey of more than 10,000 adults with MS showed that many were missing out on the seven licensed medicines approved for use.

The charity said a lack of information and access to specialists was to blame.

It is calling for the government to provide a personalised care plan to every person with MS.

Merck, Pfizer to jointly develop diabetes drug

  • Tweet
  • Share this
  • Email
  • Print

Related News

  • REFILE-UPDATE 3-Bristol-Myers Squibb sales disappoint, shares fall

    Thu, Apr 25 2013

  • Higher dose of AcelRx pain drug meets trial goal

    Wed, Apr 24 2013

  • AstraZeneca bets on nanotech with Bind Therapeutics deal

    Mon, Apr 22 2013

  • Pfizer cancer drug wins special status; shares jump

    Wed, Apr 10 2013

A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009. REUTERS/Jeff Zelevansky

1 of 2. A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009.

Credit: Reuters/Jeff Zelevansky

Mon Apr 29, 2013 8:10am EDT

Auxilium cuts sales view on drugs, expands urology business

Mon Apr 29, 2013 12:22pm EDT

(Reuters) – Auxilium Pharmaceuticals Inc reported a big fall in quarterly sales in the United States for both its drugs, and said it acquired Actient Holdings LLC to bolster its urology business.

Shares of Auxilium fell as much as 13.5 percent to $13.87 — their lowest in a year-and-a-half — on the Nasdaq on Monday.

Revenue fell 10 percent in the first quarter to $66.2 million, below analysts’ average estimate of $81.23 million, according to Thomson Reuters I/B/E/S.